Trial Profile
Thrombosis in anti-cancer therapy by bortezomib for multiple myeloma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2013
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Biomarker
- 12 Feb 2013 New trial record